Cahn Medical Technologies invests for the long term in early-stage medical
technology companies, filling the significant gap that exists between angel
investing and institutional venture capital investing rounds.
TyRx Raises $25 Million in Private Financing READ MORE

MicroMRI Receives FDA Clearance for High-Resolution MRI Wrist Coil READ MORE

TyRx Announces FDA Clearance of the AIGISRX™ Cardiac Rhythm Medical Device
Anti-Bacterial Envelope READ MORE

MicroMRI Hires New Chief Executive Officer READ MORE